funded by the Jing-jin-ji Special Projects for Basic Research Cooperation (No. J200017);the Sanming Project of the Medicine in Shenzhen (No. SZSM2019 11015);the National Natural Science Foundation of China (No. 82273721)。
Objective: This study aims to provide an analysis of the current status and trends of lung cancer incidence and mortality rates in China, comparing trends with those in the United States(U.S.).Methods: Data on lung ca...
supported by the National Natural Science Foundation of China(No.81600065 and No.82073805).
Objective:DNA methylation alterations are early events in carcinogenesis and immune signalling in lung cancer.This study aimed to develop a model based on short stature homeobox 2 gene (SHOX2)/prostaglandin E receptor...
Contents 1.Overview 2.Screening and diagnosis 2.1 Risk factors for lung cancer 2.1.1 Smoking and involuntary smoking 2.1.2 History of chronic obstructive pulmonary disease(COPD)2.1.3 Occupational exposures 2.1.4 Famil...
support from the 2019 Cancer Council NSW PhD Research Scholarship program。
Lung cancer is the leading cause of cancer-related mortality globally,accounting for 1.8 million deaths in 2020.While the vast majority are caused by tobacco smoking,15%-25%of all lung cancer cases occur in lifelong n...
supported by the National Key R&D Program of China(No.2017YFC0907900,No.2017YFC0907901,No.2017YFC1308700 and No.2017YFC1308705);National Natural Science Foundation of China(No.81773521)。
Objective:Population-level economic burden is essential for prioritizing healthcare resources and healthcare budget making in the future.However,little is known about the economic burden of lung cancer in China.Method...
the CAMS Innovation Fund for Medical Sciences(CIFMS)(No.2016-I2M-2-004);Sanming Project of Medicine in Shenzhen(No.SZSM201911015)。
China is faced with heavy burdens caused by lung cancer,which has climbed to the top of both cancer incidence and mortality spectrums.The age-standardized rates of incidence and mortality have shown a trend of gradual...
supported by National Key R&D Program of China (No. 2017YFC1308700);National Natural Science Foundation of China (No. 81602930);Chinese Academy of Medical Sciences Initiative for Innovative Medicine (No. 2017-I2M-1-005)
Objective: The objective was to systematically assess lung cancer risk prediction models by critical evaluation of methodology, transparency and validation in order to provide a direction for future model development....
supported by the Beijing Young Talent Program (No. 20160000 21469G189)
Objective: The objective of this study was to characterize secular trends in the sex-specific, age-standardized incidence of lung cancer by histological type in Beijing, China, from 2000 to 2016 based on data from a p...
the Bureau of Disease Control,National Health;Family Planning Commission of the People's Republic of China
Objective: To analyze the incidence and mortality rates of lung cancer in China from 2008 to 2012.Methods: Incident and death cases of lung cancer were retrieved from the National Central Cancer Registry(NCCR) databas...
One hundred years ago, the first patients with lung cancer have been reported (1). Since then long term survival in patients with lung cancer remains disappointing, and this is not only due to the delayed diagnosis ...